RR Kabel IPO Receives 25% Subscription on Day 1
The initial public offering (IPO) of RR Kabel, the wire and cable manufacturer, received bids for 32.87 lakh equity shares on September 13, the first day of bidding. This is equivalent to 25% of the IPO size of 1.33 crore shares.
Retail investors have subscribed 36% of the portion set aside for them, while the reserved portion of employees was subscribed 58%. High networth individuals and qualified institutional buyers (QIB) have subscribed 29% and 0.2% of their portion, respectively.
The price band for the offer is Rs 983-1,035 per share. Eligible employees will get shares at a discount of Rs 98 per share to the final issue price. The offer closes on September 15.
The global private equity giant TPG-backed company intends to raise Rs 1,964.01 crore via a maiden public issue at the upper price band. The offer comprises a fresh issuance of shares worth Rs 180 crore and an offer-for-sale of 1.72 crore shares worth Rs 1,784.01 crore by six selling shareholders including promoter Mahendrakumar Rameshwarlal Kabra, and investor TPG Asia VII SF Pte Ltd which holds 16.67 percent stake in the company.
Promoters hold 66.42 percent shares in RR Kabel and the remainder stake is held by public shareholders including TPG, the largest public shareholder in the company.
The Gujarat-based consumer electrical product maker will spend the fresh issue proceeds mainly for repaying debt amounting to Rs 136 crore, and the remainder on general corporate purposes.
RR Kabel has already mobilised Rs 585.62 crore of the total IPO fund raising, via its anchor book, a part of QIB, on September 12, a day before the issue opening.
Marquee investors who participated in the anchor book included Carmignac Portfolio, HSBC Global, Abu Dhabi Investment Authority, Ashoka Whiteoak ICAV, Government Pension Fund Global, TIMF Holdings, Elara India Opportunities Fund, Morgan Stanley Asia (Singapore), ICICI Prudential, Axis Mutual Fund, HDFC Mutual Fund, Aditya Birla Sun Life Trustee, Kotak Mutual Fund, and Franklin Mutual Fund.
RR Kabel is the fastest-growing consumer electrical company among its peers in India, growing at a CAGR of 43.4 percent during FY21-FY23.
- 22 Sep
Samhi Hotels Stock Lists with 6.75% Premium, Analysts Recommend Booking Profits
Samhi Hotels stock made a weak debut on the stock exchanges, listing at a premium of just 6.75% over the IPO price. Several analysts have recommended booking profits in the stock, citing its loss-making status and negative net worth.
- 22 Sep
Signature Global IPO Subscribed 11.88 Times on Final Day
The Signature Global IPO was subscribed 11.88 times on the final day of bidding. The company will use the proceeds to repay debt and for land acquisitions and general corporate purposes. The IPO is expected to list on October 4, but this may change due to the new timeline of T+3.
- 22 Sep
Sai Silks IPO Oversubscribed 4.4 Times on Final Day of Bidding
Sai Silks IPO was oversubscribed 4.4 times on the final day of bidding, with qualified institutional buyers and high networth individuals supporting the issue on closing day. The net fresh issue proceeds will be utilized by the company mainly for the setting up of 30 new stores, two warehouses, working capital requirements and repaying debts. The trading in its equity shares will commence with effect from October 4, as per the IPO schedule.
- 22 Sep
Pharma company Valiant Laboratories to go public on September 27
Pharma company Valiant Laboratories is going public on September 27 at a price band of Rs 133-140 per share. The company plans to raise Rs 152.46 crore via the IPO. Proceeds will be used to fund the expenditure for setting up a manufacturing facility for speciality chemicals and for working capital requirements and general corporate purposes. Valiant Laboratories is a Mumbai-based API and bulk drug manufacturing company with a focus on Paracetamol. It is owned by the promoters including Dhanvallabh Ventures LLP, which holds 62.5 percent shareholding. Valiant Organics, the listed entity on the BSE and NSE, is the promoter of Dhanvallabh Ventures LLP with 73.15 percent stake.
- 21 Sep
Unihealth Consultancy makes tepid debut on NSE Emerge
Unihealth Consultancy, a healthcare service provider, made a tepid debut on the NSE Emerge platform on September 21, listing at Rs 135, a 2.2 percent premium over its issue price of Rs 132. The stock was trading at Rs 137.30 at 11.40 am. The company has a number of positives going for it, such as its strong growth potential, its diversified business model, and its focus on the African market. However, investors who are considering investing in Unihealth Consultancy should carefully consider the company's fundamentals, the current market conditions, and their own risk appetite before making a decision.